Essentials to Consider Before You Decide to Grow Your Own Cannabis
Growing cannabis at home can be quite simple if you have enough space, either indoors or outdoors, the right equipment, and plenty of preparation
DetailsGrowing cannabis at home can be quite simple if you have enough space, either indoors or outdoors, the right equipment, and plenty of preparation
DetailsDENVER–(BUSINESS WIRE)–Escape Artists, a leader in cannabis-infused wellness products, today announced its foray into the dedicated sleep product category with the launch of Escape Artists Sleep Tincture, now available at…
DetailsNEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Rite Aid Corporation (NYSE: RAD) resulting from allegations that Rite Aid may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Rite Aid securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrange
DetailsNEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 26, 2018 and March 13, 2023, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Rite Aid investors under the federal securities laws. To join the Rite Aid class action, go to https://rosenlegal.com/submit-form/?case_id=9388 or call Phillip Kim, Esq.
DetailsNEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Innovative Industrial Properties,…
DetailsNEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Innovative Industrial Properties, Inc. (NYSE: IIPR,…
DetailsLA JOLLA, Calif.–(BUSINESS WIRE)–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced…
DetailsRuling Reiterated That Republic Tobacco Willfully Infringed on RAW Trademark and Copyright and Awarded Nearly $1.5 Million to RAW NEW YORK–(BUSINESS WIRE)–RAW (BBK/HBI), the independent global brand of high-quality rolling…
DetailsDUBLIN–(BUSINESS WIRE)–The “Environmental Law Reporter Online” newsletter has been added to ResearchAndMarkets.com’s offering. Established at the beginning of the environmental law and policy movement, ELR is the one-stop shop for…
DetailsEnveric to initiate preclinical development of EB-003 in 2024 in preparation for IND submission CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the…
DetailsPoster details advances in screening for non-hallucinogenic, neuroplastogen drug candidates for the treatment of mental health disorders CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company…
DetailsCAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced that Joseph Tucker, Ph.D., Chief Executive Officer, will present at the Gravitas Securities Inc. 6th Annual Growth Conference being held Thursday, March 2, 2023, at the Fairmont Pacific Rim Hotel in Vancouver, British Columbia
Details